R&G Pharma Studies Co.,Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Beijing China (2008)

Organization Overview

First Clinical Trial
2013
NCT01944774
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

R&G Pharma Studies Co.,Ltd.